BIOSTEM TECHNOLOGIES, INC.
Last · NasdaqCM$2.44-0.03 (-1.21%)stale · yahoo · 58h ago
Market cap$45.56M18.7M sh
P/E · TTM2.8fwd 8.4 · eps 0.88
Beta0.50vs S&P 500
Div yield0.00%annual · TTM
52w range
$2.251$8.40
Volume36.8Ksession
| Revenue | $14.0M |
|---|---|
| Operating income | $-17.3M |
| Net income | $-17.8M |
| Free cash flow | $-6.4M |
| Operating margin | -123.2% |
| Net margin | -126.8% |
| Return on equity | -64.4% |
| Period | 2026 |
Loading chart…
Upcoming earnings
9:00 PM UTC+1
Period
Sep 2026
Est. EPS
−$0.43
Est. revenue
7.2M
Earnings transcripts
- Issuer webcast
Webcast Replay
BIOSTEM TECHNOLOGIES, INC.
- Issuer webcast
Webcast (Replay)
BIOSTEM TECHNOLOGIES, INC.
- Issuer webcast
Replay Webcast
BIOSTEM TECHNOLOGIES, INC.
- Issuer webcast
Webcast Replay
BIOSTEM TECHNOLOGIES, INC.
- Issuer webcast
Webcast Replay
BIOSTEM TECHNOLOGIES, INC.
- Issuer webcast
Webcast Replay
BIOSTEM TECHNOLOGIES, INC.
Press & signals
- GlobeNewswire
BioStem Technologies’ CEO and COO Invest $1 Million in Cash Through Exercise of Stock Options
- GlobeNewswire
Terminal1, the operating system built for public companies, announced today that BioStem Technologies, Inc. (NASDAQ: BSEM) has joined the Terminal1 platform
- GlobeNewswire
BioStem Technologies Secures Up to $40 Million in a Committed Equity Facility
The rest of this company's wire — with summaries and source links — is part of Pro.
See plansDocuments
FormReporting forFiledFlags